STILL DISEASE
Clinical trials for STILL DISEASE explained in plain language.
Never miss a new study
Get alerted when new STILL DISEASE trials appear
Sign up with your email to follow new studies for STILL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tracks how ILARIS works in everyday care for rare inflammatory diseases
Disease control Recruiting nowThis study looks at how patients with Familial Mediterranean Fever (FMF) or Still's disease (including juvenile and adult forms) are treated with the drug canakinumab (ILARIS) in real-world clinics across Europe and Israel. Researchers will track 160 people who have been on the d…
Matched conditions: STILL DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:58 UTC
-
500 patients join forces to unlock the secrets of still disease
Knowledge-focused Recruiting nowThis study is collecting information from 500 adults and children with Still disease, a rare inflammatory condition causing fevers, joint pain, and rash. Researchers aim to compare how the disease affects different age groups and find better ways to diagnose and treat it. Partici…
Matched conditions: STILL DISEASE
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 26, 2026 04:59 UTC